Target Details
| UniProt AC | P29597 |
|---|---|
| Gene Symbol | TYK2 |
| Protein Name | Non-receptor tyrosine-protein kinase TYK2 |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF18379 (FERM_F1) PF18377 (FERM_F2) PF17887 (Jak1_Phl) PF07714 (PK_Tyr_Ser-Thr) PF21990 (SH2_1) |
Summary
- Multi-target molecules 3,837
- Clinical molecules 19
- Avg pChEMBL 7.56
KEGG Pathways (17)
- Coronavirus disease - COVID-19
- Epstein-Barr virus infection
- Hepatitis B
- Hepatitis C
- Herpes simplex virus 1 infection
- Human papillomavirus infection
- Influenza A
- JAK-STAT signaling pathway
- Kaposi sarcoma-associated herpesvirus infection
- Measles
- NOD-like receptor signaling pathway
- Necroptosis
- Osteoclast differentiation
- Th1 and Th2 cell differentiation
- Th17 cell differentiation
- Toll-like receptor signaling pathway
- Toxoplasmosis
Associated Diseases (2)
Active Molecules (3,837)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
SHFUHQSXZWFPTI
|
10.8 | IC50 | 2 | — | |
GTPHOMRIDNXGGJ
|
10.5 | IC50 | 2 | — | |
BRDKHBSREKWDRJ
|
10.4 | IC50 | 2 | — | |
LKRZSJNSORSCQK
|
10.4 | IC50 | 2 | — | |
BMCPTSQGNDXHRM
|
10.3 | Ki | 2 | — | |
GSDVWJCRSRGXIK
|
10.3 | Ki | 2 | — | |
GSDVWJCRSRGXIK
|
10.3 | Ki | 2 | — | |
KOAWGIGASSLEKT
|
10.3 | Ki | 2 | — | |
KYRONTAIYLIEAW
|
10.3 | Ki | 2 | — | |
LMDUNANGIDSICP
|
10.3 | Ki | 2 | — | |
NIGTUDCZQLMAMK
|
10.3 | Ki | 2 | — | |
OTKLTGWIICYAMB
|
10.3 | Ki | 2 | — | |
RNMYPPKMCCBMOT
|
10.3 | Ki | 2 | — | |
RVZLDZZOWHTMFD
|
10.3 | Ki | 2 | — | |
SOILFKONQVDFLK
|
10.3 | Ki | 2 | — | |
UFUDRLFPYOSDDJ
|
10.3 | Ki | 2 | — | |
VFTJNENCGPYFLW
|
10.3 | Ki | 2 | — | |
ZAPBDZYXECJSNK
|
10.3 | Ki | 2 | — | |
ZAPBDZYXECJSNK
|
10.3 | Ki | 2 | — | |
ZAPBDZYXECJSNK
|
10.3 | Ki | 2 | — | |
MCRCGCWWWPPTGL
|
10.2 | Kd | 4 | — | |
ACXRPKBVTFNUBE
|
10.1 | IC50 | 4 | — | |
DFAZSOUFLNOONE
|
10.1 | Ki | 4 | — | |
DFAZSOUFLNOONE
|
10.1 | Ki | 4 | — | |
QHHRTNNXPWXSMX
|
10.1 | Ki | 4 | — | |
SKSCGXZQWKQMTE
|
10.1 | IC50 | 4 | — | |
XUBODOZNSMBJOD
|
10.1 | IC50 | 4 | — | |
BTBFTXUWTWNIKT
|
10.0 | IC50 | 2 | — | |
KVBOPBBDFWSJDC
|
10.0 | IC50 | 2 | — | |
LKVGAGUADUKDMR
|
10.0 | IC50 | 2 | — | |
NBQVWXBZRRONIZ
|
10.0 | IC50 | 2 | — | |
OTPJVMYSVBYNCZ
|
10.0 | IC50 | 4 | — | |
OWVZXDARVXCWGD
|
10.0 | IC50 | 2 | — | |
OZYZRDPFUYSTRC
|
10.0 | IC50 | 2 | — | |
QQXVWTLPOIVDFQ
|
10.0 | IC50 | 2 | — | |
QYJHZOLXCAAEGZ
|
10.0 | IC50 | 2 | — | |
YPDWOKUTTYJCDR
|
10.0 | IC50 | 2 | — | |
ZMWGNLCJZDGQBV
|
10.0 | IC50 | 2 | — | |
DJUAJWMTCKJXRM
|
10.0 | Kd | 4 | — | |
RKDYFKWEFAJOHF
|
10.0 | IC50 | 4 | — | |
KFPFHFNFCCTGOO
|
9.9 | IC50 | 4 | — | |
NBQVWXBZRRONIZ
|
9.9 | IC50 | 2 | — | |
BFBCSHXBVZNRRU
|
9.9 | IC50 | 2 | — | |
QQXVWTLPOIVDFQ
|
9.9 | IC50 | 2 | — | |
SPQRBCVHNZXRER
|
9.9 | IC50 | 2 | — | |
NWGRIRNDHVPEDQ
|
9.9 | IC50 | 4 | — | |
COSYLMZYNGUKPD
|
9.8 | IC50 | 3 | — | |
LWEXBVKOJGMKLH
|
9.8 | IC50 | 4 | — | |
XILQGGMJGFCSKZ
|
9.8 | IC50 | 4 | — | |
HXQVZOBVKQEION
|
9.8 | IC50 | 2 | — |